BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kleynhans J, Sathekge M, Ebenhan T. Obstacles and Recommendations for Clinical Translation of Nanoparticle System-Based Targeted Alpha-Particle Therapy. Materials (Basel) 2021;14:4784. [PMID: 34500873 DOI: 10.3390/ma14174784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kozempel J, Sakmár M, Janská T, Vlk M. Study of (213)Bi and (211)Pb Recoils Release from (223)Ra Labelled TiO(2) Nanoparticles. Materials (Basel) 2022;16. [PMID: 36614682 DOI: 10.3390/ma16010343] [Reference Citation Analysis]
2 Sinha A, Simnani FZ, Singh D, Nandi A, Choudhury A, Patel P, Jha E, Chouhan RS, Kaushik NK, Mishra YK, Panda PK, Suar M, Verma SK. The translational paradigm of nanobiomaterials: Biological chemistry to modern applications. Mater Today Bio 2022;17:100463. [PMID: 36310541 DOI: 10.1016/j.mtbio.2022.100463] [Reference Citation Analysis]
3 Salih S, Alkatheeri A, Alomaim W, Elliyanti A. Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges. Molecules 2022;27:5231. [DOI: 10.3390/molecules27165231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Tronchin S, Forster JC, Hickson K, Bezak E. Dosimetry in targeted alpha therapy. A systematic review: current findings and what is needed. Phys Med Biol 2022;67:09TR01. [DOI: 10.1088/1361-6560/ac5fe0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]